 |
|
Study of sugars on cell surface identifies key factor in flu infection
January 07, 2008Scientists have identified a key factor that determines the ability of influenza viruses to infect cells of the human upper respiratory tract-a necessary step for sustaining spread between people. The research, described in the January 6 online edition of Nature Biotechnology and funded by the National Institutes of Health (NIH), offers new insights into how the H5N1 avian flu virus currently circulating in birds would have to change in order to gain a foothold in human populations.
The H5N1 virus has infected several hundred people, but person-to-person transmission has been limited. To trigger a widespread outbreak, experts agree that the bird flu virus must infect the cells lining our noses and throats. We then would spread the virus to others through coughing or sneezing. The latest study, led by Ram Sasisekharan, Ph.D., of the Massachusetts Institute of Technology in Cambridge, refines this notion: The virus can gain access only through a subset of the sugar molecules coating the cells of our upper airways.
"Using an approach that combines experimentation and database analysis, Sasisekharan's team has changed our view of flu viruses and how they must adapt to infect us," said Jeremy M. Berg, Ph.D., director of the National Institute of General Medical Sciences, the NIH component that supported the research. "The work may improve our ability to monitor the evolution of the H5N1 virus and thwart potential outbreaks."
Chains of sugars called glycans sit on the surface of our cells and control the gates through which different molecules enter. For a virus to gain access to a cell, proteins on the virus's surface must bind to certain glycans.
The binding protein for flu viruses is hemagglutinin. The protein can vary with each flu strain and, as a result, latch on to glycans from different types of cells. While the protein from human-adapted flu viruses favors the sugars dotting the cells of the nose and throat, the one from bird flu viruses opts for glycans on cells deeper in the respiratory tract.
Sasisekharan noted that recent studies have shown that the hemagglutinin protein from bird flu viruses has on occasion attached to glycans of the upper airways. The surprising finding, he explained, is that the virus didn't always spread effectively.
"This was a conundrum," said Sasisekharan.
To solve it, he and his team turned to the Consortium for Functional Glycomics (CFG), an initiative supported by NIGMS to explore the interactions between proteins and different types of sugars.
Mining data from the CFG glycan array, a tool for quickly screening protein-glycan binding preferences, Sasisekharan began to explore the structures of the different sugar chains coating upper respiratory tract cells.
"We found remarkable diversity," he said. "Even though these glycans are all linked the same way chemically, they have very different shapes."
According to the results, glycans of upper respiratory tract cells come in two main varieties: short and cone-shaped, and long and umbrella-shaped.
When the researchers combined this information with data from experiments and the glycan array, they found that the hemagglutinin protein from human-adapted flu viruses attached specifically to the long glycans of the upper respiratory tract. They also confirmed that the hemagglutinin from H5N1 viruses bound mainly to the cone-shaped glycans found in the lower respiratory tract.
These findings suggest that for the H5N1 bird flu virus to infect people and sustain its spread in humans, it must adapt so that it can latch onto the umbrella-shaped glycans of the upper respiratory tract.
"Until now, we had an incomplete understanding of avian flu hemagglutinin and how the protein must adapt to humans," said Sasisekharan.
The new knowledge may unlock strategies for tracking mutations in the avian flu virus that allow it to bind to long glycans, point to new therapeutic targets for both seasonal and pandemic flu, and expand our basic knowledge of glycans and their diversity.
NIH/National Institute of General Medical Sciences
Chains of sugars called glycans sit on the surface of our cells and control the gates through which different molecules enter. For a virus to gain access to a cell, proteins on the virus's surface must bind to certain glycans.
The binding protein for flu viruses is hemagglutinin. The protein can vary with each flu strain and, as a result, latch on to glycans from different types of cells. While the protein from human-adapted flu viruses favors the sugars dotting the cells of the nose and throat, the one from bird flu viruses opts for glycans on cells deeper in the respiratory tract.
Sasisekharan noted that recent studies have shown that the hemagglutinin protein from bird flu viruses has on occasion attached to glycans of the upper airways. The surprising finding, he explained, is that the virus didn't always spread effectively.
"This was a conundrum," said Sasisekharan.
To solve it, he and his team turned to the Consortium for Functional Glycomics (CFG), an initiative supported by NIGMS to explore the interactions between proteins and different types of sugars.
Mining data from the CFG glycan array, a tool for quickly screening protein-glycan binding preferences, Sasisekharan began to explore the structures of the different sugar chains coating upper respiratory tract cells.
"We found remarkable diversity," he said. "Even though these glycans are all linked the same way chemically, they have very different shapes."
According to the results, glycans of upper respiratory tract cells come in two main varieties: short and cone-shaped, and long and umbrella-shaped.
When the researchers combined this information with data from experiments and the glycan array, they found that the hemagglutinin protein from human-adapted flu viruses attached specifically to the long glycans of the upper respiratory tract. They also confirmed that the hemagglutinin from H5N1 viruses bound mainly to the cone-shaped glycans found in the lower respiratory tract.
These findings suggest that for the H5N1 bird flu virus to infect people and sustain its spread in humans, it must adapt so that it can latch onto the umbrella-shaped glycans of the upper respiratory tract.
"Until now, we had an incomplete understanding of avian flu hemagglutinin and how the protein must adapt to humans," said Sasisekharan.
The new knowledge may unlock strategies for tracking mutations in the avian flu virus that allow it to bind to long glycans, point to new therapeutic targets for both seasonal and pandemic flu, and expand our basic knowledge of glycans and their diversity.
NIH/National Institute of General Medical Sciences
Hemagglutinin News and Current Hemagglutinin Events RSSThe pandemic potential of H9N2 avian influenza viruses
Since their introduction into land-based birds in 1988, H9N2 avian influenza A viruses have caused multiple human infections and become endemic in domestic poultry in Eurasia.
New vaccine may give long-term defense against deadly bird flu and its variant forms
A new vaccine under development may provide protection against highly pathogenic bird flu and its evolving forms, according to researchers at Purdue University and the Centers for Disease Control and Prevention who discovered the new preventative drug and have tested it in mice.
Scientists create first successful libraries of avian flu virus antibodies
An international group of American and Turkish research scientists, led by Sea Lane Biotechnologies, has created the first comprehensive monoclonal antibody libraries against avian influenza (H5N1) using samples from survivors of the 2005/2006 "bird flu" outbreak in Turkey.
MIT explains spread of 1918 flu
MIT researchers have explained why two mutations in the H1N1 avian flu virus were critical for viral transmission in humans during the 1918 pandemic outbreak that killed at least 50 million people.
MIT finds key to avian flu in humans
MIT researchers have uncovered a critical difference between flu viruses that infect birds and humans, a discovery that could help scientists monitor the evolution of avian flu strains and aid in the development of vaccines against a deadly flu pandemic.
Structure of influenza B virus protein gives clues to next pandemic
Determining the structure of a protein called hemagglutinin on the surface of influenza B is giving researchers at Baylor College of Medicine and Rice University in Houston clues as to what kinds of mutations could spark the next flu pandemic.
NIH scientists target future pandemic strains of H5N1 avian influenza
Preparing vaccines and therapeutics that target a future mutant strain of H5N1 influenza virus sounds like science fiction, but it may be possible, according to a team of scientists at the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and a collaborator at Emory University School of Medicine.
Bypassing eggs, flu vaccine grown in insect cells shows promise
An experimental flu vaccine made in insect cells - not in eggs, where flu vaccines currently available in the United States are grown - is safe and as effective as conventional vaccines in protecting people against the flu, according to results published in the April 11 issue of the Journal of the American Medical Association.
Experimental flu vaccine appears promising in early tests
An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine.
Flu shot might also offer some protection against H5N1
The yearly influenza vaccine that health officials urge people to get each fall might also offer certain individuals some cross protection against the H5N1 virus, commonly known as bird flu, according to investigators at St. Jude Children's Research Hospital.
More Hemagglutinin News Articles
| © 2008 BrightSurf.com |